Online intervention for sexual health concerns in gynecologic cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research evaluates an adapted online intervention aimed at addressing sexual health issues faced by gynecologic cancer survivors. Participants will complete baseline questionnaires and undergo a 4-week waiting period before being randomized into one of four groups receiving either cognitive-behavioral therapy (CBT) or mindfulness-based therapy (MBT), with or without navigator support. The intervention involves weekly or biweekly modules over 8-16 weeks, with assessments of usability and outcomes related to sexual distress and function. The goal is to enhance access to sexual health resources for survivors, particularly those facing barriers to care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* self-report a current or history of gynecologic cancer of any subtype
* self-report symptoms of sexual difficulties and score of greater than 11 on the Female Sexual Distress Scale-Revised
* are fluent in English (eSense content is delivered in English)
* have reliable internet access and basic competency in using online platforms (individuals will self-report)
* are available for 8 - 16 weeks and able to complete eSense modules and associated questionnaires
* any gender

Exclusion Criteria:

* have visual impairments or disabilities interfering with reading and ability to interact with online materials
* have poorly managed anxiety or mood disorder (assessed using the degree of life interference evaluation at screening)
* individuals who are in active treatment for their cancer (including radiation, chemotherapy and any planned surgeries).

Where it's running

• University of British Columbia
  Vancouver, British Columbia, Canada Recruiting

Study contacts

• Principal investigator: Lori A Brotto, PhD, RPsych — University of British Columbia
• Study coordinator: Nisha Marshall, MSc
• Email: nisha.marshall@cw.bc.ca
• Phone: 6048754111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Immunonutrition and Brain Monitoring to See if Delirium Happens After Gynecologic Cancer Surgery

  This study tests whether a preoperative immunonutrition scoring plus intraoperative brain monitoring can help predict or relate to postoperative delirium in women aged 65 and older undergoing major gynecologic cancer surgery.

  Recruiting Elazıg Fethi Sekin Sehir Hastanesi · Elâzığ, Elâzığ · NCT07877285

• Prophylactic subcutaneous drainage after gynecologic cancer surgery

  This study tests whether placing a small drain under the skin after gynecologic cancer surgery helps prevent wound problems in women with thicker tissue under the skin.

  Recruiting Başakşehir Çam & Sakura City Hospital · Istanbul · NCT07735962

• Feasibility of high-dose multimodal prehabilitation for women awaiting gynecologic cancer surgery

  This study tests whether a high-dose, multimodal prehabilitation program can be delivered before gynecologic cancer surgery and whether patients prefer in-person, remote, or education-only approaches.

  Recruiting Queen's University · Kingston, Ontario · NCT07609082

• Romiplostim N01 plus ATRA for persistent chemotherapy-induced low platelets after remission from gynecologic, breast, or lung cancer

  This trial tests whether adding ATRA to Romiplostim N01 helps people keep a safe platelet count after finishing chemotherapy for certain cancers.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT07586826

• Sexual well-being in people treated for gynecologic cancer and their partners

  This project will follow people with gynecologic cancer and their partners to see if their sexual function changes over time using questionnaires and brief exams.

  Recruiting Casa di Cura Dott. Pederzoli · Bologna, Bologna and 5 other locations · NCT07557342

• Personalized diet to help women with advanced gynecologic or breast cancer on ADC therapy

  This study tests a personalized dietary plan versus general Mediterranean diet guidance in women with advanced gynecologic or breast cancer who are being treated with antibody-drug conjugates to see if nutrition can improve quality of life.

  Recruiting Phase 2 TNC Nutrición Terapéutica S.L. · Madrid, Madrid · NCT07406789

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.